Evaluating results of an interferon-? release assay in patients with autoimmune disease who are taking hydroxychloroquine - 14/03/19
Supported by the United States Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development and Biomedical Laboratory Research and Development). |
|
Conflicts of interest: None disclosed. |
|
Presented in limited form at the Rheumatologic Dermatology Society meeting, November 2017, in San Diego, California and at the International Investigative Dermatology meeting, May 2018, in Orlando, Florida. |
Vol 80 - N° 4
P. 1162-1164 - avril 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.